RxDoctor Payments Data

Hadas Skupsky, MD

Procedural Dermatology · Long Beach, CANPI 1093032658

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.

$5,647in general payments, 2019–2025

Across 220 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • LEO Pharma Inc.$656
  • Sanofi$649
  • Regeneron Healthcare Solutions, Inc.$511
  • Johnson & Johnson$370
  • Lilly USA, LLC$306
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,54898%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,647 in reported general payments places this provider in the 65th percentile of 108 procedural dermatology providers in California.

See all procedural dermatology providers in California

Medicare billing

Part B allowed, 2024
$457,973
Medicare patients
1,430
Services billed
7,592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate18$1,241
Desonide23$850
Clobetasol Propionate22$771
Fluocinonide15$469
ValacyclovirValacyclovir Hcl19$240
Minoxidil20$221
Mupirocin18$200
Ketoconazole15$178

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →